Stock listing
NASDAQ:HOTH Hoth Therapeutics, Inc. Stock
Home listing (NASDAQ) of Hoth Therapeutics, Inc.
Follow Hoth Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:HOTH
$0.28 USD -0.02 (-7.4%)
Close on Nov 19, 2026 · Data provided by Twelve Data
- Day range
- $0.272 – $0.31 USDNov 19, 2026
- Volume
- 271,337 sharesNov 19, 2026
- Market cap
- $4.55M USDAt the close on Nov 19, 2026 · price × 16.27M shares outstanding
- 52-week range
- $0.272 – $2.45 USDLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
- Traded on an average day
- $219,012 USDMedian day 242,281 shares · last 3 months, Aug 19, 2026 – Nov 19, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:HOTH · Home | $0.28 USD | -0.022 (-7.4%) | 271,337 | $0.302 | $0.31 | $0.272 | $0.302 | Close on Nov 19, 2026 |
Daily closes
Last 3 months, Aug 19, 2026 – Nov 19, 2026 · NASDAQ:HOTH · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.28 | -0.022 | -7.4% | $0.302 | $0.31 | $0.272 | 271,337 | |
| $0.302 | -0.015 | -4.6% | $0.321 | $0.322 | $0.301 | 62,638 | |
| $0.317 | -0.004 | -1.2% | $0.324 | $0.324 | $0.301 | 258,851 | |
| $0.321 | +0.00 | 0.0% | $0.33 | $0.336 | $0.308 | 162,333 | |
| $0.321 | -0.024 | -7.0% | $0.335 | $0.345 | $0.316 | 221,785 | |
| $0.345 | -0.026 | -7.0% | $0.36 | $0.374 | $0.345 | 148,885 | |
| $0.371 | -0.009 | -2.4% | $0.37 | $0.383 | $0.332 | 620,978 | |
| $0.38 | -0.015 | -3.9% | $0.399 | $0.399 | $0.37 | 154,625 | |
| $0.395 | -0.006 | -1.4% | $0.402 | $0.408 | $0.391 | 148,899 | |
| $0.401 | -0.001 | -0.2% | $0.402 | $0.425 | $0.391 | 123,804 | |
| $0.402 | -0.04 | -9.1% | $0.44 | $0.44 | $0.38 | 393,395 | |
| $0.442 | -0.02 | -4.3% | $0.436 | $0.475 | $0.434 | 321,430 | |
| $0.462 | +0.013 | +2.9% | $0.47 | $0.499 | $0.43 | 1,270,852 | |
| $0.449 | -0.037 | -7.7% | $0.487 | $0.498 | $0.441 | 248,547 | |
| $0.487 | -0.029 | -5.6% | $0.516 | $0.525 | $0.47 | 331,367 | |
| $0.516 | -0.027 | -5.0% | $0.551 | $0.551 | $0.51 | 131,506 | |
| $0.543 | +0.005 | +1.0% | $0.537 | $0.553 | $0.535 | 117,337 | |
| $0.537 | +0.027 | +5.4% | $0.51 | $0.55 | $0.50 | 265,852 | |
| $0.51 | -0.038 | -6.8% | $0.55 | $0.555 | $0.507 | 181,144 | |
| $0.548 | +0.015 | +2.8% | $0.533 | $0.557 | $0.528 | 98,821 | |
| $0.533 | +0.007 | +1.4% | $0.52 | $0.548 | $0.51 | 313,260 | |
| $0.525 | -0.006 | -1.1% | $0.549 | $0.55 | $0.522 | 170,718 | |
| $0.531 | +0.034 | +6.9% | $0.538 | $0.58 | $0.53 | 942,224 | |
| $0.497 | -0.01 | -2.0% | $0.501 | $0.539 | $0.483 | 426,388 | |
| $0.507 | -0.03 | -5.6% | $0.549 | $0.55 | $0.503 | 236,014 | |
| $0.537 | +0.005 | +0.9% | $0.536 | $0.547 | $0.51 | 200,156 | |
| $0.532 | -0.038 | -6.7% | $0.57 | $0.57 | $0.53 | 305,237 | |
| $0.571 | -0.029 | -4.9% | $0.602 | $0.61 | $0.563 | 602,603 | |
| $0.60 | -0.049 | -7.6% | $0.65 | $0.651 | $0.595 | 309,353 | |
| $0.649 | +0.003 | +0.5% | $0.657 | $0.678 | $0.647 | 111,256 | |
| $0.646 | -0.024 | -3.6% | $0.668 | $0.68 | $0.633 | 262,321 | |
| $0.67 | -0.031 | -4.5% | $0.695 | $0.695 | $0.665 | 198,963 | |
| $0.701 | -0.009 | -1.2% | $0.73 | $0.765 | $0.687 | 1,209,980 | |
| $0.71 | +0.012 | +1.8% | $0.69 | $0.726 | $0.66 | 287,664 | |
| $0.698 | +0.007 | +1.0% | $0.71 | $0.724 | $0.694 | 177,365 | |
| $0.691 | -0.024 | -3.3% | $0.715 | $0.73 | $0.688 | 125,153 | |
| $0.714 | -0.017 | -2.4% | $0.715 | $0.746 | $0.713 | 149,318 | |
| $0.732 | -0.007 | -0.9% | $0.73 | $0.738 | $0.713 | 115,991 | |
| $0.738 | -0.029 | -3.8% | $0.745 | $0.775 | $0.73 | 205,291 | |
| $0.768 | +0.008 | +1.0% | $0.77 | $0.799 | $0.755 | 138,924 | |
| $0.76 | +0.008 | +1.1% | $0.74 | $0.771 | $0.733 | 255,714 | |
| $0.752 | -0.029 | -3.7% | $0.773 | $0.792 | $0.741 | 284,516 | |
| $0.781 | +0.033 | +4.4% | $0.737 | $0.84 | $0.73 | 1,287,800 | |
| $0.749 | -0.041 | -5.2% | $0.81 | $0.835 | $0.749 | 320,051 | |
| $0.79 | 0.00 | 0.0% | $0.789 | $0.81 | $0.77 | 190,986 | |
| $0.79 | -0.112 | -12.4% | $0.86 | $0.86 | $0.78 | 374,771 | |
| $0.902 | +0.165 | +22.4% | $0.74 | $0.928 | $0.74 | 2,259,615 | |
| $0.737 | +0.066 | +9.9% | $0.67 | $0.76 | $0.664 | 943,166 | |
| $0.671 | +0.03 | +4.7% | $0.62 | $0.71 | $0.62 | 443,311 | |
| $0.641 | -0.005 | -0.7% | $0.66 | $0.673 | $0.619 | 189,308 | |
| $0.645 | -0.02 | -3.0% | $0.665 | $0.665 | $0.63 | 181,871 | |
| $0.665 | -0.031 | -4.4% | $0.676 | $0.69 | $0.665 | 158,017 | |
| $0.696 | +0.001 | +0.2% | $0.681 | $0.70 | $0.671 | 154,486 | |
| $0.694 | +0.003 | +0.5% | $0.696 | $0.706 | $0.675 | 181,562 | |
| $0.691 | -0.001 | -0.1% | $0.69 | $0.71 | $0.68 | 192,179 | |
| $0.691 | +0.011 | +1.7% | $0.68 | $0.706 | $0.68 | 147,172 | |
| $0.68 | -0.007 | -1.1% | $0.68 | $0.72 | $0.68 | 177,131 | |
| $0.688 | -0.022 | -3.2% | $0.68 | $0.70 | $0.68 | 178,874 | |
| $0.71 | -0.012 | -1.7% | $0.721 | $0.724 | $0.695 | 260,534 | |
| $0.722 | -0.003 | -0.4% | $0.721 | $0.74 | $0.72 | 283,836 | |
| $0.725 | -0.014 | -1.9% | $0.735 | $0.739 | $0.721 | 165,527 | |
| $0.739 | +0.001 | +0.1% | $0.716 | $0.744 | $0.716 | 273,533 | |
| $0.738 | -0.007 | -1.0% | $0.739 | $0.745 | $0.692 | 345,654 | |
| $0.745 | -0.008 | -1.1% | $0.747 | $0.755 | $0.73 | 534,457 | |
| $0.754 | -0.011 | -1.4% | $0.761 | $0.765 | $0.72 | 431,954 | |
| $0.764 | +0.002 | +0.3% | $0.74 | $0.78 | $0.74 | 353,029 |
- Ticker
- NASDAQ:HOTH
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news
Hoth Therapeutics: Rocket One Reports Approximately $8.4 Million in Cash and Cash Equivalents and Outlines Strategy Across AI Infrastructure, Spintronic Computing for Space and Defense Markets
Jun 15, 2026
Closed $1.03 (-7.6%) on Jun 15, 2026
Hoth Therapeutics Awarded U.S. Patent for Cancer-Fighting HT-KIT Oncology Platform
May 26, 2026
Closed $0.708 (+2.7%) on May 26, 2026
AI Chip Energy Efficiency: Hoth Therapeutics Restructures as Rocket One Inc. to Enter the AI Semiconductor Infrastructure Market with Acquisition of Exclusive Rights to Next Generation AI Semiconductor Acceleration Technology Built on Non-Volatile Nan...
May 19, 2026
Closed $0.60 (-2.1%) on May 19, 2026
Hoth Therapeutics Secures European Authorization in Spain for HT-001 Phase 2a Trial as Interim Data Show Strong Efficacy in Cancer Patients
May 5, 2026
Closed $0.74 (+4.2%) on May 6, 2026
Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide
Apr 14, 2026
Closed $0.646 (+26.2%) on Apr 14, 2026
Hoth Therapeutics Announces Closing of $2.0 Million Registered Direct Offering
Apr 2, 2026
Closed $0.562 (+2.7%) on Apr 2, 2026
Hoth Therapeutics Announces $2.0 Million Registered Direct Offering
Apr 1, 2026
Closed $0.547 (-34.9%) on Apr 1, 2026
Hoth Therapeutics Announces Issuance of Chinese Patent for Cancer Cell-Targeting Technology
Mar 31, 2026
Closed $0.84 (+9.1%) on Mar 31, 2026
Hoth Therapeutics Deploys OpenClaw™ AI Platform to Accelerate Drug Discovery
Mar 26, 2026
Closed $0.839 (-6.7%) on Mar 26, 2026
Hoth Therapeutics, Inc. on 6ix
- News releases
- 22 in the last 12 months · 203 in all · newest Jun 15, 2026 · oldest 2019
- Decks
- 7 decks · latest October 2025
Where Hoth Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:HOTH · Home listing · This page | NASDAQ | United States | USD |
| BOATS:HOTH | BOATS | United States | USD |
Valuation
price Nov 19, 2026
- Enterprise value
- No statements on 6ix yet
- P/E
- No statements on 6ix yet
- EV/sales
- No statements on 6ix yet
- EV/EBITDA
- No statements on 6ix yet
- Price/book
- No statements on 6ix yet
- Gross margin
- No statements on 6ix yet
- Operating margin
- No statements on 6ix yet
- Net margin
- No statements on 6ix yet
- Debt to equity
- No statements on 6ix yet
- Beta vs S&P 500
- 1.73
Team and board
| Officer | Role |
|---|---|
| Robb Knie | Founder, President, and Chief Executive Officer |
| David Briones | Chief Financial Officer |
| Hayley Springer | Executive Vice President Operations |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (October 2025) | Investor deck | 24 slides | October 2025 |
| Investor Presentation (June 2025) | Investor deck | 28 slides | June 2025 |
| Investor Presentation (December 2024) | Investor deck | 33 slides | December 2024 |
| Investor Presentation (August 2023) | Investor deck | 33 slides | August 2023 |
| Investor Presentation (September 2022) | Investor deck | 39 slides | September 2022 |
| Investor Presentation (April 2022) | Investor deck | 46 slides | April 2022 |
| Investor Presentation (October 2019) | Investor deck | 33 slides | October 2019 |
Cap table
Built by 6ix from Hoth Therapeutics, Inc.’s releases
- Common shares
- 16,270,499
- Fully diluted
- 16,270,499
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 16,270,499 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 16,270,499 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Anthony C. Hayes Other companies: SIM Acquisition Corp. I (Director · Since at least Mar 7, 2026); Dominari Holdings Inc. (CEO & Chairman of the Board · Since at least Sep 10, 2013); Revelation Biosciences, Inc. (Director · Oct 7, 2020 – Oct 7, 2020 · Past) | Director · Feb 14, 2019 – Dec 31, 2019 · Past |
| David Briones Other companies: Unique Logistics International Inc (Director · Sep 6, 2022 – May 14, 2025 · Past); ZyVersa Therapeutics, Inc. (Chief Financial Officer, Director · Dec 20, 2021 – Jan 6, 2022 · Past) | Chief Financial Officer · Since at least Mar 5, 2019 |
| Wayne D. Linsley Other companies: Silo Pharma, Inc. (Board Member · Since at least May 23, 2025); Myseum.AI, Inc. (Director · Since at least Jan 14, 2025) | Director · Jul 17, 2023 – Aug 19, 2024 · Past |
| Christopher Michael Camarra | Director · May 8, 2025 – May 8, 2025 · Past |
| Hayley Springer | Executive Vice President Operations · Since at least Nov 5, 2026 |
| Robb Knie | Founder, President, and Chief Executive Officer · Since at least May 26, 2026 |
Log in to ask 6ix AI your own questions about Hoth Therapeutics, Inc.